{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:07:53Z","timestamp":1790755673523,"version":"4.1.0"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI 15\/1597 to E.G."],"award-info":[{"award-number":["PI 15\/1597 to E.G."]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1093\/brain\/awy105","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T15:10:54Z","timestamp":1522336254000},"page":"1609-1621","source":"Crossref","is-referenced-by-count":239,"title":["JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis"],"prefix":"10.1093","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0664-9751","authenticated-orcid":false,"given":"Leandro","family":"Ladislau","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Association Institut de Myologie, Center of Research in Myology, UMRS 974, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France"},{"name":"Instituto de Biof\u00edsica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Su\u00e1rez-Calvet","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Association Institut de Myologie, Center of Research in Myology, UMRS 974, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France"},{"name":"Neuromuscular Diseases Unit, Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona and Institut de Recerca Sant Pau, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9gol\u00e8ne","family":"Toquet","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Association Institut de Myologie, Center of Research in Myology, UMRS 974, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oc\u00e9ane","family":"Landon-Cardinal","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Association Institut de Myologie, Center of Research in Myology, UMRS 974, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Amelin","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Association Institut de Myologie, Center of Research in Myology, UMRS 974, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Depp","sequence":"additional","affiliation":[{"name":"Laboratory of Neurogenetics and Neuroinflammation, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) UMR1163 and Universit\u00e9 Paris Descartes, Universit\u00e9 Sorbonne Paris Cit\u00e9, Institut Imagine, 75015 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu P","family":"Rodero","sequence":"additional","affiliation":[{"name":"Laboratory of Neurogenetics and Neuroinflammation, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) UMR1163 and Universit\u00e9 Paris Descartes, Universit\u00e9 Sorbonne Paris Cit\u00e9, Institut Imagine, 75015 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisa","family":"Hathazi","sequence":"additional","affiliation":[{"name":"Leibniz-Institut f\u00fcr Analytische Wissenschaften - ISAS - e.V, Biomedical Research Department, Tissue Omics group, Otto-Hahn-Str. 6b, 44227, Dortmund, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darragh","family":"Duffy","sequence":"additional","affiliation":[{"name":"INSERM UMR 1223 and Laboratory of Dendritic Cell Immunobiology, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bondet","sequence":"additional","affiliation":[{"name":"INSERM UMR 1223 and Laboratory of Dendritic Cell Immunobiology, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Preusse","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Charit\u00e9 University, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Bienvenu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Saint Joseph Hospital, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flore","family":"Rozenberg","sequence":"additional","affiliation":[{"name":"Departement de Virologie, H\u00f4pital Cochin, Paris Descartes Universit\u00e9s, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Roos","sequence":"additional","affiliation":[{"name":"Leibniz-Institut f\u00fcr Analytische Wissenschaften - ISAS - e.V, Biomedical Research Department, Tissue Omics group, Otto-Hahn-Str. 6b, 44227, Dortmund, Germany"},{"name":"Institute of Genetic Medicine, John Walton Muscular Dystrophy Research Centre, International Centre for Life, Central Parkway, Newcastle upon Tyne, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia F","family":"Benjamim","sequence":"additional","affiliation":[{"name":"Instituto de Biof\u00edsica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Gallardo","sequence":"additional","affiliation":[{"name":"Neuromuscular Diseases Unit, Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona and Institut de Recerca Sant Pau, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Illa","sequence":"additional","affiliation":[{"name":"Neuromuscular Diseases Unit, Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona and Institut de Recerca Sant Pau, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Mouly","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Association Institut de Myologie, Center of Research in Myology, UMRS 974, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Stenzel","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, Charit\u00e9 University, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Butler-Browne","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Association Institut de Myologie, Center of Research in Myology, UMRS 974, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Association Institut de Myologie, Center of Research in Myology, UMRS 974, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Allenbach","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, Association Institut de Myologie, Center of Research in Myology, UMRS 974, AP-HP, Department of Internal Medicine and Clinical Immunology, DHU I2B, Piti\u00e9-Salp\u00eatri\u00e8re Hospital, F-75013, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"key\n\t\t\t\t20180525035850_awy105-B1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12613748","article-title":"HMEC-1: establishment of an immortalized human microvascular endothelial cell line","volume":"99","author":"Ades","year":"1992","journal-title":"J Invest Dermatol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ajpath.2015.11.010","article-title":"Dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies: common interferon signature but distinct NOS2 expression","volume":"186","author":"Allenbach","year":"2016","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B3","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/bjd.13915","article-title":"Validation of the cutaneous dermatomyositis disease area and severity index: characterizing disease severity and assessing responsiveness to clinical change","volume":"173","author":"Anyanwu","year":"2015","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B4","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nprot.2010.6","article-title":"In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract","volume":"5","author":"Arnaoutova","year":"2010","journal-title":"Nat Protoc"},{"key":"key\n\t\t\t\t20180525035850_awy105-B5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.24902","article-title":"Pathogenic role of anti-SRP and anti-HMGCR antibodies in necrotizing myopathies: myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies","volume":"81","author":"Arouche-Delaperche","year":"2017","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B6","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ymthe.2004.08.007","article-title":"Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo","volume":"10","author":"Arsic","year":"2004","journal-title":"Mol Ther"},{"key":"key\n\t\t\t\t20180525035850_awy105-B7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","article-title":"An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity","volume":"13","author":"Baechler","year":"2007","journal-title":"Mol Med"},{"key":"key\n\t\t\t\t20180525035850_awy105-B8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/annrheumdis-2017-211555","article-title":"Novel therapies for immune-mediated inflammatory diseases: what can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?","volume":"77","author":"Baker","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180525035850_awy105-B9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/1535-7163.MCT-05-0324","article-title":"Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention","volume":"5","author":"Bertl","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"Pt 13","key":"key\n\t\t\t\t20180525035850_awy105-B10","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1242\/jcs.144907","article-title":"Cellular microenvironments reveal defective mechanosensing responses and elevated YAP signaling in LMNA-mutated muscle precursors","volume":"127","author":"Bertrand","year":"2014","journal-title":"J Cell Sci"},{"key":"key\n\t\t\t\t20180525035850_awy105-B11","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1212\/WNL.0b013e31821f440a","article-title":"Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies","volume":"76","author":"Cappelletti","year":"2011","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180525035850_awy105-B12","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1093\/brain\/awq270","article-title":"Aids to the investigation of peripheral nerve injuries. Medical Research Council: Nerve Injuries Research Committee. His Majesty's Stationery Office: 1942; pp. 48 (iii) and 74 figures and 7 diagrams; with aids to the examination of the peripheral nervous system. By Michael O'Brien for the Guarantors of Brain. Saunders Elsevier: 2010; pp. [8] 64 and 94 Figures","volume":"133","author":"Compston","year":"2010","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180525035850_awy105-B13","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180525035850_awy105-B14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrrheum.2010.2","article-title":"Immunotherapy of myositis: issues, concerns and future prospects","volume":"6","author":"Dalakas","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2990.2010.01153.x","article-title":"Review: an update on inflammatory and autoimmune myopathies","volume":"37","author":"Dalakas","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMc1506827","article-title":"Inflammatory muscle diseases","volume":"373","author":"Dalakas","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180525035850_awy105-B17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180525035850_awy105-B18","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180525035850_awy105-B19","doi-asserted-by":"crossref","first-page":"8595","DOI":"10.1038\/s41598-017-09309-8","article-title":"Hypoxia triggers IFN-I production in muscle: implications in dermatomyositis","volume":"7","author":"De Luna","year":"2017","journal-title":"Sci Rep"},{"issue":"91","key":"key\n\t\t\t\t20180525035850_awy105-B20","first-page":"e51312","article-title":"Endothelial cell tube formation assay for the in vitro study of angiogenesis","author":"DeCicco-Skinner","year":"2014","journal-title":"J Vis Exp"},{"key":"key\n\t\t\t\t20180525035850_awy105-B21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/dbio.1994.1193","article-title":"Clones of human satellite cells can express in vitro both fast and slow myosin heavy chains","volume":"164","author":"Edom","year":"1994","journal-title":"Dev Biol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mayocp.2012.10.017","article-title":"Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations","volume":"88","author":"Ernste","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t20180525035850_awy105-B23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1124\/dmd.117.078048","article-title":"The JAK1\/2 inhibitor ruxolitinib reverses interleukin-6-mediated suppression of drug-detoxifying proteins in cultured human hepatocytes","volume":"46","author":"Febvre-James","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"key\n\t\t\t\t20180525035850_awy105-B24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t20180525035850_awy105-B25","doi-asserted-by":"crossref","first-page":"e65362","DOI":"10.1371\/journal.pone.0065362","article-title":"Type 1 interferons inhibit myotube formation independently of upregulation of interferon-stimulated gene 15","volume":"8","author":"Franzi","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180525035850_awy105-B26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40259-013-0040-7","article-title":"The arrival of JAK inhibitors: advancing the treatment of immune and hematologic disorders","volume":"27","author":"Furumoto","year":"2013","journal-title":"BioDrugs"},{"key":"key\n\t\t\t\t20180525035850_awy105-B27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/path.4355","article-title":"Sustained autoimmune mechanisms in dermatomyositis","volume":"233","author":"Greenberg","year":"2014","journal-title":"J Pathol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00019052-200406000-00018","article-title":"Uncertainties in the pathogenesis of adult dermatomyositis","volume":"17","author":"Greenberg","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/gene.2011.61","article-title":"Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis","volume":"13","author":"Greenberg","year":"2012","journal-title":"Genes Immun"},{"key":"key\n\t\t\t\t20180525035850_awy105-B30","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B31","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/WNL.59.8.1170","article-title":"Molecular profiles of inflammatory myopathies","volume":"59","author":"Greenberg","year":"2002","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180525035850_awy105-B32","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.23884","article-title":"Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis","volume":"58","author":"Grundtman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180525035850_awy105-B33","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood-2013-03-484642","article-title":"The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo","volume":"122","author":"Heine","year":"2013","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180525035850_awy105-B34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20180525035850_awy105-B35","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1056\/NEJMc1412997","article-title":"Remission of recalcitrant dermatomyositis treated with ruxolitinib","volume":"371","author":"Hornung","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180525035850_awy105-B36","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/bjd.15006","article-title":"Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon \u03b2 in dermatomyositis","volume":"176","author":"Huard","year":"2017","journal-title":"Br J Dermatol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nri3875","article-title":"Translating nucleic acid-sensing pathways into therapies","volume":"15","author":"Junt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B39","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jamadermatol.2016.0866","article-title":"Tofacitinib citrate for refractory cutaneous dermatomyositis: an alternative treatment","volume":"152","author":"Kurtzman","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"Pt 7","key":"key\n\t\t\t\t20180525035850_awy105-B40","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/brain\/aww122","article-title":"Microvascular alterations and the role of complement in dermatomyositis","volume":"139","author":"Lahoria","year":"2016","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180525035850_awy105-B41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jneuroim.2015.06.009","article-title":"Role of Toll-like receptors and retinoic acid inducible gene I in endogenous production of type I interferon in dermatomyositis","volume":"285","author":"Li","year":"2015","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B42","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/ard.2010.139949","article-title":"Interferon \u03b2 is associated with type 1 interferon-inducible gene expression in dermatomyositis","volume":"70","author":"Liao","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180525035850_awy105-B43","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/art.22558","article-title":"Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis","volume":"56","author":"L\u00f3pez de Padilla","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180525035850_awy105-B44","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/art.1780400514","article-title":"Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies","volume":"40","author":"Lundberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180525035850_awy105-B45","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.bbadis.2014.05.034","article-title":"Dermatomyositis, polymyositis and immune-mediated necrotising myopathies","volume":"1852","author":"Luo","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20180525035850_awy105-B46","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1182\/blood-2013-02-482232","article-title":"A comprehensive review and analysis of the effect of ruxolitinib therapy on the survival of patients with myelofibrosis","volume":"121","author":"Mascarenhas","year":"2013","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180525035850_awy105-B47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)00121-5","article-title":"TGFbeta signaling in growth control, cancer, and heritable disorders","volume":"103","author":"Massagu\u00e9","year":"2000","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180525035850_awy105-B48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0967-5868(02)00271-0","article-title":"Inflammatory myopathies: how to treat the difficult cases","volume":"10","author":"Mastaglia","year":"2003","journal-title":"J Clin Neurosci"},{"key":"key\n\t\t\t\t20180525035850_awy105-B49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/jcb.21833","article-title":"Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes","volume":"105","author":"Menconi","year":"2008","journal-title":"J Cell Biochem"},{"key":"key\n\t\t\t\t20180525035850_awy105-B50","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cell.2016.06.024","article-title":"AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies","volume":"166","author":"Meyer","year":"2016","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180525035850_awy105-B51","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/art.24555","article-title":"Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy","volume":"60","author":"Niewold","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180525035850_awy105-B52","doi-asserted-by":"crossref","first-page":"R651","DOI":"10.1152\/ajpregu.00069.2007","article-title":"Delayed angiogenesis and VEGF production in CCR2-\/- mice during impaired skeletal muscle regeneration","volume":"293","author":"Ochoa","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B53","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.semarthrit.2016.08.009","article-title":"A case of refractory dermatomyositis responsive to tofacitinib","volume":"46","author":"Paik","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"key\n\t\t\t\t20180525035850_awy105-B54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/viro.2000.0627","article-title":"Antibody-dependent induction of type I interferons by poliovirus in human mononuclear blood cells requires the type II fcgamma receptor (CD32)","volume":"278","author":"Palmer","year":"2000","journal-title":"Virology"},{"key":"key\n\t\t\t\t20180525035850_awy105-B55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mus.21651","article-title":"Vascular pathology in dermatomyositis and anatomic relations to myopathology","volume":"42","author":"Pestronk","year":"2010","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20180525035850_awy105-B56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","article-title":"Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis","volume":"16","author":"Presta","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"key\n\t\t\t\t20180525035850_awy105-B57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40478-016-0308-5","article-title":"Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis","volume":"4","author":"Preu\u00dfe","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"key\n\t\t\t\t20180525035850_awy105-B58","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1002\/acr.20532","article-title":"Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res"},{"key":"key\n\t\t\t\t20180525035850_awy105-B59","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.20161451","article-title":"Detection of interferon alpha protein reveals differential levels and cellular sources in disease","volume":"214","author":"Rodero","year":"2017","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20180525035850_awy105-B60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.21805","article-title":"Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy","volume":"67","author":"Salajegheh","year":"2010","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B61","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1074\/jbc.R700016200","article-title":"JAK-STAT signaling: from interferons to cytokines","volume":"282","author":"Schindler","year":"2007","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180525035850_awy105-B62","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B63","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/path.4346","article-title":"Altered RIG-I\/DDX58-mediated innate immunity in dermatomyositis","volume":"233","author":"Su\u00e1rez-Calvet","year":"2014","journal-title":"J Pathol"},{"key":"key\n\t\t\t\t20180525035850_awy105-B64","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13075-017-1383-0","article-title":"RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis","volume":"19","author":"Su\u00e1rez-Calvet","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"key\n\t\t\t\t20180525035850_awy105-B65","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJMoa1608345","article-title":"Baricitinib versus Placebo or Adalimumab in rheumatoid arthritis","volume":"376","author":"Taylor","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180525035850_awy105-B66","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/art.33350","article-title":"Immature muscle precursors are a source of interferon-\u03b2 in myositis: role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation","volume":"64","author":"Tournadre","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180525035850_awy105-B67","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe?","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20180525035850_awy105-B68","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","article-title":"Sarcoplasmic MxA expression: a valuable marker of dermatomyositis","volume":"88","author":"Uruha","year":"2017","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180525035850_awy105-B69","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/art.22928","article-title":"Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180525035850_awy105-B70","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/leu.2013.205","article-title":"Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348)","volume":"28","author":"Zhou","year":"2014","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180525035850_awy105-B71","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrrheum.2011.39","article-title":"Pathogenesis, classification and treatment of inflammatory myopathies","volume":"7","author":"Zong","year":"2011","journal-title":"Nat Rev Rheumatol"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/141\/6\/1609\/24855009\/awy105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T14:05:33Z","timestamp":1570975533000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/141\/6\/1609\/4993951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":71,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,5,8]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awy105","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,5,8]]}}}